Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes

Diabetes Technology and Therapeutics

Volumn 19, Issue 5, 2017, Pages 293-298

  Deboer, Mark D ^a   Breton, Marc D ^a   Wakeman, Christian ^a   Schertz, Elaine M ^a   Emory, Emma G ^a   Robic, Jessica L ^a   Kollar, Laura L ^a   Kovatchev, Boris P ^a   Cherñavvsky, Daniel R ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TypeZero Technologies   (United States)

Author keywords

Artificial pancreas; Children; Closed loop control; Glycemic control; Type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HOME CARE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; MOBILE APPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ACTIVITY TRACKER; ADVERSE DEVICE EFFECT; ANALYSIS; BLOOD; CHEMICALLY INDUCED; CHILD BEHAVIOR; CLINICAL TRIAL; COMPUTER SECURITY; DAILY LIFE ACTIVITY; EXERCISE; HYPERGLYCEMIA; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; UNIVERSITY HOSPITAL; VIRGINIA;

ACTIVITIES OF DAILY LIVING; BLOOD GLUCOSE; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; COMPUTER SECURITY; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; EXERCISE; FEASIBILITY STUDIES; FEMALE; FITNESS TRACKERS; HOSPITALS, UNIVERSITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; OUTPATIENT CLINICS, HOSPITAL; PANCREAS, ARTIFICIAL; VIRGINIA;

EID: 85019541870     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2016.0424     Document Type: Article

References (20)

1. Beck RW, Tamborlane WV, Bergenstal RM, et al.: The T1D exchange clinic registry. J Clin Endocrinol Metab 2012; 97: 4383-4389.
2. Miller KM, Foster NC, Beck RW, et al.: Current state of type 1 diabetes treatment in the U. S.: updated data from the T1D exchange clinic registry. Diabetes Care 2015; 38: 971-978.
3. Del Favero S, Boscari F, Messori M, et al.: Randomized summer camp crossover trial in 5-to 9-year-old children: outpatient wearable artificial pancreas is feasible and safe. Diabetes Care 2016; 39: 1180-1185.
4. Chernãvvsky DR, DeBoer MD, Keith-Hynes P, et al.: Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus. Pediatr Diabetes 2016; 17: 28-35.
5. Tauschmann M, Allen JM, Wilinska ME, et al.: Home use of day-and-night hybrid closed-loop insulin delivery in suboptimally controlled adolescents with type 1 diabetes: a 3-week, free-living, randomized crossover trial. Diabetes Care 2016; 39: 2019-2025.
6. Wadams H, Chernãvvsky DR, Lteif A, et al.: Closed-loop control for pediatric type 1 diabetes mellitus. Diabetes Manage 2015; 5: 23-35.
7. Forlenza GP, Buckingham B, Maahs DM: Progress in diabetes technology: developments in insulin pumps, continuous glucose monitors, and progress towards the artificial pancreas. J Pediatr 2016; 169: 13-20.
8. Phillip M, Battelino T, Atlas E, et al.: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013; 368: 824-833.
9. Ly TT, Breton MD, Keith-Hynes P, et al.: Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care 2014; 37: 2310-2316.
10. Russell SJ, El-Khatib FH, Sinha M, et al.: Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014; 371: 313-325.
11. Anderson SM, Raghinaru D, Pinsker JE, et al.: Multinational home use of closed-loop control is safe and effective. Diabetes Care 2016; 39: 1143-1150.
12. Leelarathna L, Dellweg S, Mader JK, et al.: Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study. Diabetes Care 2014; 37: 1931-1937.
13. Brown SA, Kovatchev BP, Breton MD, et al.: Multinight ''bedside'' closed-loop control for patients with type 1 diabetes. Diabetes Technol Ther 2015; 17: 203-209.
14. Ly TT, Buckingham BA, DeSalvo DJ, Shanmugham S, et al.: Day-and-night closed-loop control using the unified safety system in adolescents with type 1 diabetes at camp. Diabetes Care 2016; 39: e106-e107.
15. The Diabetes Control and Complications Trial Research Group: Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA 1996; 276: 1409-1415.
16. Siminerio LM, Albanese-O'Neill A, Chiang JL, et al.: Care of young children with diabetes in the child care setting: a position statement of the American Diabetes Association. Diabetes Care 2014; 37: 2834-2842.
17. Nabors L, Lehmkuhl H, Christos N, Andreone TL: Children with diabetes: perceptions of supports for self-management at school. J Sch Health 2003; 73: 216-221.
18. Kovatchev BP, Renard E, Cobelli C, et al.: Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 2014; 37: 1789-1796.
19. Elleri D, Allen JM, Tauschmann M, et al.: Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3-6 years: comparison between diluted and standard insulin strength. BMJ Open Diabetes Res Care 2014; 2: e000040.
20. Wallen MP, Gomersall SR, Keating SE, et al.: Accuracy of heart rate watches: implications for weight management. PLoS One 2016; 11: e0154420.